Agilent Technologies Inc  

(Public, NYSE:A)   Watch this stock  
Find more results for A
+0.82 (1.36%)
After Hours: 60.61 0.00 (0.00%)
Jun 22, 4:22PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 59.61 - 60.80
52 week 41.98 - 61.15
Open 59.94
Vol / Avg. 3.47M/2.25M
Mkt cap 19.30B
P/E 34.03
Div/yield 0.13/0.87
EPS 1.78
Shares 321.34M
Beta 1.25
Inst. own 89%
Aug 15, 2017
Q3 2017 Agilent Technologies Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 14, 2017
Agilent Technologies Inc at Goldman Sachs Global Healthcare Conference - Webcast
Jun 6, 2017
Agilent Technologies Inc at Jefferies Healthcare Conference - Webcast
May 22, 2017
Q2 2017 Agilent Technologies Inc Earnings Call - Webcast
May 22, 2017
Q2 2017 Agilent Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '17) 2016
Net profit margin 14.88% 10.99%
Operating margin 18.24% 14.64%
EBITD margin - 22.75%
Return on average assets 8.28% 6.05%
Return on average equity 15.18% 10.99%
Employees 12,900 -
CDP Score - -


5301 Stevens Creek Blvd
SANTA CLARA, CA 95051-7201
United States - Map
+1-408-3458886 (Phone)
+1-408-3458474 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Officers and directors

Michael R. McMullen President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Didier Hirsch Chief Financial Officer, Senior Vice President
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tang Senior Vice President, General Counsel, Secretary
Age: 42
Bio & Compensation  - Reuters
Dominique P. Grau Senior Vice President - Human Resources
Age: 57
Bio & Compensation  - Reuters
Henrik Ancher-Jensen Senior Vice President, President - Order Fulfillment
Age: 51
Bio & Compensation  - Reuters
Mark Doak Senior Vice President, President - Agilent CrossLab Group
Age: 61
Bio & Compensation  - Reuters
Patrick K. Kaltenbach Senior Vice President, President - Life Sciences and Applied Markets Group
Age: 53
Bio & Compensation  - Reuters
Samraat Raha Senior Vice President - Strategy and Corporate Development
Bio & Compensation  - Reuters
Jacob Thaysen Senior Vice President, President - Diagnostics and Genomics Group
Age: 41
Bio & Compensation  - Reuters
Rodney Gonsalves Chief Accounting Officer, Vice President, Corporate Controller
Age: 51
Bio & Compensation  - Reuters